varespladib has been researched along with Rheumatoid Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arjunan, P; Gopalakrishnakone, P; Kumar, PV; Nagarajarao, LM; Ramapatna, SL; Sato, K; Satyanarayanajois, SD; Thwin, MM | 1 |
| Bradley, JD; Dmitrienko, AA; Gluck, OS; Kivitz, AJ; Myers, SL; Sides, GD; Weaver, AL; Wiesenhutter, C | 1 |
1 trial(s) available for varespladib and Rheumatoid Arthritis
| Article | Year |
|---|---|
A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Indoles; Keto Acids; Middle Aged; Phospholipases A; Phospholipases A2; Placebos | 2005 |
1 other study(ies) available for varespladib and Rheumatoid Arthritis
| Article | Year |
|---|---|
Novel peptide inhibitors of human secretory phospholipase A2 with antiinflammatory activity: solution structure and molecular modeling.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cells, Cultured; Circular Dichroism; Fibroblasts; Gene Expression; Humans; Magnetic Resonance Spectroscopy; Matrix Metalloproteinases; Models, Molecular; Oligopeptides; Peptides; Peptides, Cyclic; Phospholipases A2, Secretory; Protein Binding; Protein Conformation; Rabbits; Solutions; Structure-Activity Relationship; Synovial Fluid | 2007 |